CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,154,000 | -46.6% | 285,133 | -57.3% | 0.07% | -53.1% |
| Q2 2021 | $7,773,000 | +214.2% | 667,224 | +229.0% | 0.14% | +163.6% |
| Q1 2021 | $2,474,000 | -61.2% | 202,806 | -60.2% | 0.06% | -67.5% |
| Q4 2020 | $6,381,000 | -53.6% | 510,088 | -44.2% | 0.17% | -62.5% |
| Q3 2020 | $13,766,000 | -14.8% | 914,662 | +38.7% | 0.45% | -29.5% |
| Q2 2020 | $16,162,000 | – | 659,395 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |